Clinical Trial Update: Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients. [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing labetalol to hydralazine for severe hypertension in obstetric patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension in Pregnancy
• Pre-eclampsia

Drugs mentioned

• Hydralazine (hydralazine)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Hypertension, Pregnancy Induced, Hydralazine Adverse Reaction | Phase 2 | Status: COMPLETED